Iridex (IRIX) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -33.21% |
| Jan 3, 2026 | -34.14% |
| Sep 27, 2025 | -36.26% |
| Jun 28, 2025 | -32.19% |
| Mar 29, 2025 | -65.81% |
| Dec 28, 2024 | -55.19% |
| Sep 28, 2024 | -53.04% |
| Jun 29, 2024 | -45.94% |
| Mar 30, 2024 | -36.76% |
| Dec 30, 2023 | -18.15% |
| Sep 30, 2023 | -11.24% |
| Jul 1, 2023 | -10.55% |
| Apr 1, 2023 | -9.10% |
| Dec 31, 2022 | -8.79% |
| Oct 1, 2022 | -9.00% |
| Jul 2, 2022 | -8.81% |
| Apr 2, 2022 | -8.06% |
| Jan 1, 2022 | -8.04% |
| Oct 2, 2021 | -8.08% |
| Jul 3, 2021 | 3.23% |
| Apr 3, 2021 | -2.00% |
| Jan 2, 2021 | -17.14% |
| Sep 26, 2020 | -21.08% |
| Jun 27, 2020 | -20.63% |
| Mar 28, 2020 | -19.03% |
| Dec 28, 2019 | -16.61% |
| Sep 28, 2019 | -11.45% |
| Jun 29, 2019 | -9.45% |
| Mar 30, 2019 | -7.06% |
| Dec 29, 2018 | -3.83% |
| Sep 29, 2018 | -0.21% |
| Jun 30, 2018 | -9.74% |
| Mar 31, 2018 | -7.11% |
| Dec 30, 2017 | -3.28% |
| Sep 30, 2017 | 11.07% |
| Jul 1, 2017 | 13.49% |
| Apr 1, 2017 | 14.46% |
| Dec 31, 2016 | 14.84% |
| Oct 1, 2016 | 11.27% |
| Jul 2, 2016 | 12.52% |
| Apr 2, 2016 | 13.92% |
| Jan 2, 2016 | 15.43% |
| Oct 3, 2015 | 11.37% |
| Jul 4, 2015 | 10.30% |
| Apr 4, 2015 | 11.92% |
| Jan 3, 2015 | 14.58% |
| Sep 27, 2014 | 5.88% |
| Jun 28, 2014 | 6.70% |
| Dec 28, 2013 | 10.00% |